Rosemary Liu

Rosemary is the New Ventures and Transactions Lead for Cardiovascular and Metabolic (CVM) Diseases at Johnson & Johnson Innovation, London. In this role, Rosemary is responsible for sourcing and executing on the delivery of transformational, innovative opportunities for healthcare in the Cardiovascular and Metabolic space across EMEA. Before this role, Rosemary was a Healthcare Solutions Lead for Johnson & Johnson Health & Wellness Solutions, based in the UK. Previously, Rosemary was a Director on the Medical Devices Equity Research team at Oppenheimer & Co. in New York City. Rosemary started her career as an investment banking analyst at Merrill Lynch. Rosemary holds an MBA from London Business School and a BA in Economics and Psychology from the University of Virginia.